These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 20592416

  • 1. Population pharmacokinetic investigation of digoxin in Japanese infants and young children.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E, Akiyama K, Suematsu F, Yukawa M, Minemoto M.
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [Abstract] [Full Text] [Related]

  • 3. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    Drugs Aging; 2011 Oct 01; 28(10):831-41. PubMed ID: 21970310
    [Abstract] [Full Text] [Related]

  • 4. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F, Yukawa E, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y.
    Eur J Clin Pharmacol; 2001 Apr 01; 57(1):19-24. PubMed ID: 11372585
    [Abstract] [Full Text] [Related]

  • 5. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T.
    J Clin Pharmacol; 1997 Feb 01; 37(2):92-100. PubMed ID: 9055134
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    J Clin Pharm Ther; 2011 Dec 01; 36(6):704-10. PubMed ID: 22023343
    [Abstract] [Full Text] [Related]

  • 7. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
    Choi SA, Yun HY, Lee ES, Shin WG.
    Clin Ther; 2014 Mar 01; 36(3):389-400. PubMed ID: 24612944
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants.
    Gong Y, Chen Y, Li Q, Li Z.
    J Pharmacol Sci; 2014 Mar 01; 125(2):142-9. PubMed ID: 24837877
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
    Araki R, Yukawa E, Nakashima MN, Fukuchi H, Sasaki H, Yano K, Nakashima M.
    Ther Drug Monit; 2011 Dec 01; 33(6):750-6. PubMed ID: 22105593
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T.
    Clin Pharmacokinet; 2001 Dec 01; 40(10):773-81. PubMed ID: 11707062
    [Abstract] [Full Text] [Related]

  • 11. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES, Madabushi R, Amry Sel-D, Bhattaram VA, Derendorf H.
    Am J Ther; 2005 Dec 01; 12(4):320-7. PubMed ID: 16041195
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of digoxin in children with congestive heart failure aggravated by other diseases.
    Lares-Asseff I, Juárez-Olguín H, Flores-Pérez J, Bobadilla-Chávez J.
    Rev Invest Clin; 2004 Dec 01; 56(1):32-7. PubMed ID: 15144040
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y, Somsaard P, Petcharattana S.
    J Med Assoc Thai; 2009 Oct 01; 92(10):1324-35. PubMed ID: 19845241
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of digoxin in pediatric patients.
    Martín-Suárez A, Falcao AC, Outeda M, Hernández FJ, González MC, Quero M, Arranz I, Lanao JM.
    Ther Drug Monit; 2002 Dec 01; 24(6):742-5. PubMed ID: 12451291
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES, Nagaraja NV, Derendorf H.
    Am J Ther; 2002 Dec 01; 9(6):492-8. PubMed ID: 12424506
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of digoxin in elderly patients.
    Chen R, Zou SL, Wang ML, Jiang Y, Xue H, Qian CY, Xia ZL.
    Eur J Drug Metab Pharmacokinet; 2013 Jun 01; 38(2):115-21. PubMed ID: 23096939
    [Abstract] [Full Text] [Related]

  • 17. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E, Mine H, Higuchi S, Aoyama T.
    J Pharm Pharmacol; 1992 Sep 01; 44(9):761-5. PubMed ID: 1360530
    [Abstract] [Full Text] [Related]

  • 18. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F, Minemoto M, Yukawa E, Higuchi S.
    J Clin Pharm Ther; 1999 Jun 01; 24(3):203-8. PubMed ID: 10438180
    [Abstract] [Full Text] [Related]

  • 19. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure.
    Carlton LD, Patterson JH, Mattson CN, Schmith VD.
    J Clin Pharmacol; 1996 Mar 01; 36(3):247-56. PubMed ID: 8690819
    [Abstract] [Full Text] [Related]

  • 20. [Personalized pharmacotherapy of digoxin].
    Grundmann M, Kacířová I.
    Vnitr Lek; 2015 May 01; 61(5):406-9. PubMed ID: 26075848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.